We refer to our disclosure, dated July 29, 2020, under regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, regarding agreement entered into by one of the wholly owned subsidiaries, Taro Pharmaceuticals Inc., of our subsidiary company, Taro Pharmaceutical Industries Ltd., to acquire by way of purchase of all outstanding shares of Aquinox Pharmaceuticals (Canada) Inc. Further to the above, we wish to inform you that our above-referred subsidiary has acquired, on 31st July, 2020, all the shares of Aquinox Pharmaceuticals (Canada) Inc. by making the payment of USD $8.2Mn and complying all requirements. This is for your information and dissemination

 BSE
Sat. 01, Aug 2020, 02:18 PM
SUN PHARMA
Chat with Keepup